Designer Estrogen

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Designer Estrogen

Postby thinkingoutloud86 » Tue Aug 28, 2007 4:07 am

don't know if this is new or not, but thought i would post it.

TOL ... 174327.htm

'Designer Estrogen' Identified As Potential MS Drug

Science Daily — UCLA scientists have found the first evidence that a specific form of estrogen can protect the brain from degeneration yet not increase the risk for estrogen-induced cancers of the breast and uterus. The study took place in mice infected with the animal equivalent of multiple sclerosis.

Healthy spinal cord tissue (left) shows a similar number of neurons (magnified in red) as MS-infected spinal cord tissue (right) in mice that have been treated with a specific form of estrogen. Less neurons are found in the spinal cords of mice whose disease went untreated (center). (Credit: Seema Tiwari-Woodruff/UCLA)
Ads by Google
Advertise on this site
Information About MS
Join live discussions & get Multiple Sclerosis information.
Sclerosis Symptoms
Recognize Multiple Sclerosis In Its Early Stages. Get Useful Info Here!
Natural MS Treatment?
Cleanse & Detox MS Symptoms Away! Testimonials and Research $645/Day
Conquer Symptoms of MS
Find out how you can reverse the Symptoms of Multiple Sclerosis.
Multiple Sclerosis
Top 5 Multiple Sclerosis Sites. Find Multiple Sclerosis Research.

While people with MS have many choices for anti-inflammatory drugs to help prevent flare-ups of their physical symptoms, no medication exists to stop the disorder from causing degeneration of the brain and spinal cord. The UCLA findings offer potential for a "designer estrogen" that doctors could prescribe in higher doses without increasing a patient's cancer risk, as well as a potent MS cocktail blending the hormone with a standard anti-inflammatory treatment.

This form of estrogen also offers a new weapon for combating brain degeneration caused by Alzheimer's, Parkinson's, Lou Gehrig's disease, spinal cord injury and even normal aging. Finally, men may be able to use it without fear of developing the feminine side effects often produced by standard estrogen treatments.

Researchers Dr. Rhonda Voskuhl, Jack H. Skirball Chair in Multiple Sclerosis Research and professor of neurology; and Seema Tiwari-Woodruff, assistant professor of neurology are both from the UCLA Multiple Sclerosis Program at the David Geffen School of Medicine.

The National Institute of Neurological Disorders and Stroke, National Institute of Allergy and Infectious Diseases and National Multiple Sclerosis Society supported the research.

The study appears in the Aug. 27 -- 31 online edition of the Proceedings of the National Academy of Sciences.

Note: This story has been adapted from a news release issued by University of California - Los Angeles. ... 174327.htm
User avatar
Family Elder
Posts: 122
Joined: Wed May 31, 2006 3:00 pm


Return to Drug Pipeline


  • Related topics
    Last post

Who is online

Users browsing this forum: No registered users

Contact us | Terms of Service